Early phase 1Enrolling by invitation

Truway Diagnostic Tools in Primary Care (TruDxPC)

Evaluation of Truway Health-Sourced Portable Diagnostic Devices for Early Detection of Chronic Conditions in Outpatient Primary Care Settings: A Prospective Interventional Study

Sponsor
Truway Health, Inc. (Industry)
Enrollment
200 planned
Conditions
Chronic Disease; Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight; Hypertension; Cardiovascular Disease Acute; Hyperlipidemia; Chronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD; Peripheral Artery Disease; Metabolic Syndrome; Prediabetes
Interventions
Truway Portable Ultrasound Device; Truway Blood Glucose Monitor; Standard Oral Hypoglycemic Agent
Ages
children, adults, older adults
Registry
NCT07209527

Full record on ClinicalTrials.gov

From the registry

This study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 participants will be assigned to use these devices versus standard care over a 6-month period. The primary outcome is improved diagnostic accuracy and patient outcomes. The study, led by Truway Health, Inc., aims to enhance accessible healthcare solutions starting at a New York site, with potential expansion to Miami.

Primary outcomes

  • Rate of Early Detection of Chronic Conditions
  • Improvement in Glycemic Control

History

  1. Primary completion expected

  2. Last registry update

  3. Registered

  4. Started